Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Quinine sulfate 200mg tablets
0504010Y0AAAFAF
|
Quinine sulfate | Quinine sulfate | Infections | 287,813 |
|
Quinine sulfate 300mg tablets
0504010Y0AAAHAH
|
Quinine sulfate | Quinine sulfate | Infections | 197,056 |
|
Quinine sulfate 200mg/5ml oral suspension
0504010Y0AABDBD
|
Quinine sulfate | Quinine sulfate | Infections | 66 |
|
Quinine sulfate 300mg/5ml oral suspension
0504010Y0AABCBC
|
Quinine sulfate | Quinine sulfate | Infections | 47 |
|
Quinine sulfate 100mg/5ml oral liquid
0504010Y0AAA2A2
|
Quinine sulfate | Quinine sulfate | Infections | No data available |
|
Quinine sulfate 10mg/5ml oral liquid
0504010Y0AAA6A6
|
Quinine sulfate | Quinine sulfate | Infections | No data available |
|
Quinine sulfate 125mg/5ml oral liquid
0504010Y0AABABA
|
Quinine sulfate | Quinine sulfate | Infections | No data available |
|
Quinine sulfate 150mg/5ml oral suspension
0504010Y0AAA5A5
|
Quinine sulfate | Quinine sulfate | Infections | No data available |
|
Quinine sulfate 250mg/5ml oral liquid
0504010Y0AAA7A7
|
Quinine sulfate | Quinine sulfate | Infections | No data available |
|
Quinine sulfate 25mg/5ml oral liquid
0504010Y0AABBBB
|
Quinine sulfate | Quinine sulfate | Infections | No data available |
|
Quinine sulfate 50mg/5ml oral liquid
0504010Y0AAA4A4
|
Quinine sulfate | Quinine sulfate | Infections | No data available |
|
Quinine sulfate 75mg/5ml oral liquid
0504010Y0AAA3A3
|
Quinine sulfate | Quinine sulfate | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.